Cargando…
PFKFB3 Inhibitor 3PO Reduces Cardiac Remodeling after Myocardial Infarction by Regulating the TGF-β1/SMAD2/3 Pathway
Adverse cardiac remodeling, including cardiac fibrosis, after myocardial infarction (MI) is a major cause of long-term heart failure. 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3), an enzyme that regulates glucose metabolism, also plays an important role in various fibrotic and card...
Autores principales: | Yang, Qian, Zong, Xiao, Zhuang, Lingfang, Pan, Roubai, Tudi, Xierenayi, Fan, Qin, Tao, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377206/ https://www.ncbi.nlm.nih.gov/pubmed/37509108 http://dx.doi.org/10.3390/biom13071072 |
Ejemplares similares
-
Upregulation of glycolytic enzyme PFKFB3 by deubiquitinase OTUD4 promotes cardiac fibrosis post myocardial infarction
por: Wang, Feizuo, et al.
Publicado: (2023) -
IL-6 inhibitors effectively reverse post-infarction cardiac injury and ischemic myocardial remodeling via the TGF-β1/Smad3 signaling pathway
por: Wang, Jiahong, et al.
Publicado: (2022) -
Quercetin prevents myocardial infarction adverse remodeling in rats by attenuating TGF-β1/Smad3 signaling: Different mechanisms of action
por: Albadrani, Ghadeer M., et al.
Publicado: (2021) -
Phenylacetylglutamine as a risk factor and prognostic indicator of heart failure
por: Zong, Xiao, et al.
Publicado: (2022) -
Roles of PFKFB3 in cancer
por: Shi, Linlin, et al.
Publicado: (2017)